| Literature DB >> 22530134 |
Selva Kumar Sivagnanam1, Mudiganti Ram Krishna Rao, Maruthaiveeran Periyasamy Balasubramanian.
Abstract
The present study was undertaken to test the chemopreventive effects of one herbal medicinal plant, Indigofera aspalathoides, on chemically induced carcinogenesis in rats. A well-known polyaromatic hydrocarbon, namely, 20-methylcholanthrene, which is a known carcinogenic substance, was used to induce fibrosarcoma in Wistar strain of male albino rats. Fibrosarcoma rats were treated with aqueous extracts of Indigofera aspalathoides. The rats were divided into four groups, each consisting of six animals. Group I served as normal control, Group II served as fibrosarcoma-induced animals, Group III were fibrosarcoma-bearing animals treated with aqueous extracts of Indigofera aspalathoides, and Group IV animals, which were normal healthy animals treated with Indigofera aspalathoides aqueous extract, served as drug control set. Group III and Group IV animals were treated with aqueous extract of Indigofera aspalathoides intraperitoneally at a dose of 250 mg/kg. b.w. for 30 days. The fibrosarcoma was proved by pathological examinations. The activity levels of nucleic acids such as total DNA and RNA and hexose, hexosamine, and sialic acid in liver and kidney of treated rats were used to monitor the chemopreventive role of the plant extract. The observed increase in the levels of DNA, RNA, hexose, hexosamine, and sialic acid in liver and kidney tissues of fibrosarcoma-bearing animals reached near normal state after the treatment with aqueous extracts of Indigofera aspalathoides, suggesting that Indigofera aspalathoides does have a chemotherapeutic role.Entities:
Year: 2012 PMID: 22530134 PMCID: PMC3317032 DOI: 10.5402/2012/134356
Source DB: PubMed Journal: ISRN Pharmacol ISSN: 2090-5165
Figure 1The histopathological patterns in liver before and after treatment.
Figure 2The histopathological patterns in kidney before and after treatment.
The levels of nucleic acids in liver and kidney of control and experimental animals.
| Parameters (mg/gm.wt. of tissue) | Group I (control) | Group II (fibrosarcoma) | Group III (fibrosarcoma+ | Group IV |
|---|---|---|---|---|
| Liver | ||||
| DNA | 5.45 ± 0.46 | 6.54 ± 0.25a∗ | 5.46 ± 0.45a NS b∗ | 5.32 ± 0.34aNS |
| RNA | 7.58 ± 0.27 | 8.95 ± 0.45a∗ | 7.72 ± 0.29a NS b∗ | 4.38 ± 0.22aNS |
| Kidney | ||||
| DNA | 4.42 ± 2.1 | 5.90 ± 0.54a∗ | 4.48 ± 0.29a NS b∗ | 4.38 ± 0.22aNS |
| RNA | 6.34 ± 0.38 | 7.99 ± 0.36a∗ | 6.25 ± 0.41a NS b∗ | 6.23 ± 0.42a NS |
aGroup II, III, and IV compared with Group I, bGroup III compared with Group II. Values are mean ± SD: N = 6, *p < 0.001, @p < 0.05. NS: not significant.
The levels of hexose, hexosamine, and sialic acid in liver and kidney of control and experimental animals.
| Parameters (mg/g. defatted tissue) | Group I Control | Group II Fibrosarcoma | Group III Fibrosarcoma + | Group IV |
|---|---|---|---|---|
| Liver: hexose | 19.44 ± 1.84 | 31.89 ± 2.72a∗ | 23.55 ± 2.12a@b∗ | 20.91 ± 1.66a NS |
| Hexosamine | 4.09 ± 0.36 | 8.86 ± 0.92a∗ | 5.06 ± 0.46a∗b∗ | 4.70 ± 0.32a NS |
| Sialic acid | 0.28 ± 0.02 | 0.76 ± 0.08a∗ | 0.35 ± 0.04a@b∗ | 0.29 ± 0.03a NS |
| Kidney: hexose | 18.84 ± 1.50 | 26.16 ± 3.05a∗ | 20.18 ± 2.11a@b∗ | 19.22 ± 1.75a NS |
| Hexosamine | 2.17 ± 0.17 | 3.39 ± 0.38a∗ | 2.62 ± 0.20a@b∗ | 2.27 ± 0.16a NS |
| Sialic acid | 0.30 ± 0.03 | 0.55 ± 0.07a∗ | 0.36 ± 0.05aNSb∗ | 0.32 ± 0.03a NS |
aGroup II, III, and IV compared with Group I, bGroup III compared with Group II. Values are mean ± SD: N = 6, *p < 0.001, @p < 0.05, NS: not significant.